A Case of Small Cell Lung Cancer Transformation from EGFR-Mutant Lung Adenocarcinoma with Primary Resistance to Gefitinib

被引：4
|
作者：
Chu, Xiao [1 ,2 ]
Li, Yuan [3 ,4 ]
Zhu, Zhengfei [1 ,3 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
基金：
上海市自然科学基金; 中国国家自然科学基金;
关键词：
D O I：
10.1016/j.jtho.2018.05.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E211 / E214
页数：4
相关论文
共 50 条
  • [1] Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance A case report
    Jiang, Yiqian
    Shou, Leyi
    Guo, Qingmin
    Bao, Yanhong
    Xu, Xiaoping
    An, Suhong
    Lu, Jianfeng
    [J]. MEDICINE, 2021, 100 (32) : E26911
  • [2] Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin
    Hwang, Ki-Eun
    Jung, Jae-Wan
    Oh, Su-Jin
    Park, Mi-Jeong
    Shon, Young-Jun
    Choi, Keum-Ha
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    [J]. TUMORI JOURNAL, 2015, 101 (03): : E96 - E98
  • [3] An EGFR-mutant lung adenocarcinoma that transformed into small- cell lung cancer. A case report
    Chowaniecova, Gabriela
    Berzinec, Peter
    Kosturiakova, Gabriela
    Plank, Lukas
    Farkasova, Anna
    Sekeresova, Monika
    Juskanic, Dominik
    Ondrus, Dalibor
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2022, 166 (04): : 451 - 454
  • [4] Evolutionary history of small cell lung cancer transformed from EGFR-mutant lung adenocarcinoma.
    Lee, June-Koo
    Lee, Junehawk
    Kim, Sehui
    Kim, Soyeon
    Youk, Jeonghwan
    Park, Seongyeol
    An, Yohan
    Keam, Bhumsuk
    Kim, Dong-Wan
    Heo, Dae Seog
    Kim, Young Tae
    Kim, Jin-Soo
    Kim, Se Hyun
    Lee, Jong Seok
    Lee, Se-Hoon
    Park, Keunchil
    Ku, Ja-Lok
    Jeon, Yoon Kyung
    Chung, Doo Hyun
    Park, Peter J.
    Kim, Joon
    Kim, Tae Min
    Ju, Youngseok
    [J]. CANCER RESEARCH, 2018, 78 (10) : 71 - 72
  • [5] Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
    Naito, Yoichi
    Goto, Koichi
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1027 - 1040
  • [6] Gefitinib/osimertinibDevelopment of gefitinib and osimertinib resistance and transformation of the lung adenocarcinoma to small cell lung cancer: 3 case reports
    [J]. Reactions Weekly, 2018, 1685 (1) : 96 - 96
  • [7] Gefitinib/osimertinibDevelopment of gefitinib and osimertinib resistance and transformation of the lung adenocarcinoma to small cell lung cancer: 3 case reports
    [J]. Reactions Weekly, 2018, 1695 (1) : 193 - 193
  • [8] EGFR-Mutant Adenocarcinoma Transform into Small-Cell Lung Cancer: Real or Not
    Zhang, Y.
    Li, R.
    Jiang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1019 - S1020
  • [9] Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
    Bai, Wenwen
    Zhen, Chanjun
    Zhang, Ruohui
    Yu, Wenhui
    Zhou, Zhiguo
    [J]. TRANSLATIONAL CANCER RESEARCH, 2021, 10 (08) : 3694 - 3704
  • [10] GefitinibDevelopment of acquired resistance to gefitinib with transformation of lung adenocarcinoma to metastatic small cell lung cancer: case report
    [J]. Reactions Weekly, 2022, 1899 (1) : 198 - 198
12345